A detailed history of Rock Springs Capital Management LP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 891,719 shares of VINC stock, worth $508,279. This represents 0.12% of its overall portfolio holdings.

Number of Shares
891,719
Previous 891,719 -0.0%
Holding current value
$508,279
Previous $1.05 Million 328.9%
% of portfolio
0.12%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.64 - $1.08 $138,784 - $234,199
-216,851 Reduced 19.56%
891,719 $909,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $1.72 $0 - $506,326
294,376 Added 36.16%
1,108,570 $1.53 Million
Q1 2022

May 16, 2022

BUY
$0.0 - $0.0 $0 - $0
4,999 Added 0.62%
814,194 $3.26 Million
Q4 2021

Feb 14, 2022

BUY
$0.0 - $0.0 $0 - $0
8,900 Added 1.11%
809,195 $8.25 Million
Q3 2021

Nov 15, 2021

BUY
$0.0 - $0.0 $0 - $0
800,295 New
800,295 $12.9 Million

Others Institutions Holding VINC

About Vincerx Pharma, Inc.


  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $12.1M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.